cheshta's blog

Novartis last shot to protect its anti cancer drug "Glivec"

Submitted by cheshta on Mon, 2012-03-05 09:31

In 2006 Novartis had sued Indian Government for not granting patent to its anti cancer drug Imatinib selling under brand name " Glivec". It also challenged the constitutional validity of section 3 d of Indian Patent Act 1970 which says new forms including esters, ethers, acids or other derivatives of known substance are not patentable in India unless there is increase in efficacy.

Women IPR Program by Government of India

Submitted by cheshta on Thu, 2012-01-05 19:08

“Women Scientists Scheme (WOS-C)” on IPR, a scheme of Department of Science & Technology, Government of India for the women scientists is being implemented by Patent Facilitating Centre (PFC) of Technology Information, Forecasting and Assessment Council (TIFAC).

How trademark battles affect stock market in India?

Submitted by cheshta on Wed, 2011-12-28 14:15

I was just going through the BSE this morning and found an interesting element to share with my readers. As reported by India infoline and Money Control, Tilaknagar Industries (TI) rose to 1.38% to Rs. 34.30 at 11:37 IST on the BSE after the Bombay High Court dismissed the petition filed by UTO Netherland B.V seeking restraint on brand names “ Madison – House” and “ Savoy Club”.

IPAB rejects Yahoo paidsearch technology patent

Submitted by cheshta on Tue, 2011-12-27 18:45

As reported by The Economic Times, Intellectual Property Appellate Board in Chennai has rejected a patent filed for a paidsearch technology by Overture Services Inc, a unit of  Yahoo. As per technology,, search lists is based on bid made by advertiser. For exaample, comapny A comes top in a search after bidding at 3 cents but if comapny B pays more money that will rise in listing.

Patent Database on bio resources to check bio piracy

Submitted by cheshta on Tue, 2011-12-27 17:25

Court restrains Star TV " Master Chef " Show

Submitted by cheshta on Tue, 2011-12-27 15:06

Guide to Patent Strategy in India

Submitted by cheshta on Mon, 2011-12-12 19:15

 

Guide to Patent Strategy in India

Copyright Infringement cases on rise in Bollywood

Submitted by cheshta on Sat, 2011-12-10 16:04

A for Appeal , B for Bollywood , C for Copyright.....Just a day before the date of worldwide theatrical release Justice Vinod Sharma refused to grant the plaintiff ( producers of Tamil Movie " Naan Avan Iiiai" ) an ex-parte injunction.

End of lipitor patent : Strategy of Pfizer to earn money with expired patent

Submitted by cheshta on Fri, 2011-12-02 17:58

Patent  of the one of the most blockbuster drug in the market - LIPITOR has expired. Patent was held by Pfizer which held the market exclusivity and earned great revenues at an average of $ 11 billion  with last year sales staggering at $ 13 billion. Lipitor almost amounted for one sixth of the revenue of Pfizer. Though many companies stop marketing their products at patent expiry but Pfizer is trying best to keep up his market against all generic rivals - Ranbaxy and Watson Pharmaceuticals.
 

Syndicate content